NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects Humans Remove constraint Subjects: Humans Genre Technical Report Remove constraint Genre: Technical Report Genre Guideline Remove constraint Genre: Guideline Dates by Range 2000 and later Remove constraint Dates by Range: 2000 and later

Search Results

81. Requests for feedback on medical device submissions: the pre-submission program and meetings with Food and Drug Administration staff : guidance for industry and Food and Drug Administration staff

82. Administrative procedures for CLIA categorization: guidance for industry and Food and Drug Administration staff

83. Display devices for diagnostic radiology: guidance for industry and Food and Drug Administration staff

84. M4 organization of the Common Technical Document for the Registration of Pharmaceuticals for Human Use

86. Deciding when to submit a 510(k) for a change to an existing device: guidance for Industry and Food and Drug Administration staff

87. Deciding when to submit a 510(k) for a software change to an existing device: guidance for industry and Food and Drug Administration staff

88. De novo classification process (evaluation of automatic class III designation): guidance for industry and Food and Drug Administration staff

89. Product labeling for certain ultrasonic surgical aspirator devices: guidance for Industry and Food and Drug Administration staff

90. Manufacturers sharing patient-specific information from medical devices with patients upon request: guidance for industry and Food and Drug Administration staff

93. Chronic hepatitis C virus infection: developing direct-acting antiviral drugs for treatment

94. Recurrent herpes labialis: developing drugs for treatment and prevention

95. Evaluating drug effects on the ability to operate a motor vehicle

96. Regulatory considerations for human cells, tissues, and cellular and tissue-based products: minimal manipulation and homologous use : guidance for industry and Food and Drug Administration staff

97. Same surgical procedure exception under 21 CFR 1271.15(b): questions and answers regarding the scope of the exception

98. Unique device identification: direct marking of devices : guidance for Industry and Food and Drug administration staff

99. General principles for evaluating the abuse deterrence of generic solid oral opioid drug products

100. Pediatric information for x-ray imaging device premarket notifications: guidance for industry and Food and Drug Administration staff